Shelly M. Seward

Shelly M. Seward

Gynecologic Oncology | Obstetrics and Gynecology | Oncology

83 W. Miller St.
Orlando, FL 32806

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.

Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours.

Journal: Clinical and translational medicine

Published: April 04, 2025

ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.

ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.

Journal: Future oncology (London, England)

Published: June 19, 2023

Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.

Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.

Journal: Applied immunohistochemistry & molecular morphology : AIMM

Published: December 17, 2020

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 28, 2020

Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer.

Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer.

Journal: Hematology/oncology clinics of North America

Published: November 05, 2018

Anti-N-methyl-D-aspartate receptor antibody encephalitis: An important cause of encephalitis in young adults. A report of two cases.

Anti-N-methyl-D-aspartate receptor antibody encephalitis: An important cause of encephalitis in young adults. A report of two cases.

Journal: Journal of American college health : J of ACH

Published: February 01, 2018

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.

Journal: Gynecologic oncology

Published: June 26, 2017

Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer.

Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer.

Journal: Gynecologic oncology

Published: March 17, 2017

Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.

Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.

Journal: Cancer

Published: November 03, 2016

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.

Journal: Gynecologic oncology

Published: June 03, 2016

Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma.

Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma.

Journal: Cancer metastasis reviews

Published: January 19, 2015

Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?

Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?

Journal: Gynecologic oncology

Published: September 20, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026